Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
G. Järnerot. (1996) Future Aspects on Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 31:sup220, pages 87-90.
Read now
Read now
Articles from other publishers (9)
Yunki Yau, Rupert W Leong, Ming Zeng & Valerie C Wasinger. (2013) Proteomics and metabolomics in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 28:7, pages 1076-1086.
Crossref
Crossref
M J H J Palmen, O L C Wijburg, I H Kunst, H Kroes & E P Van Rees. (1998) CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells. Clinical and Experimental Immunology 112:2, pages 216-225.
Crossref
Crossref
S.J.H. Van Deventer. (1999) Review article: targeting TNFα as a key cytokine in the inflammatory processes of Crohn’s disease - the mechanisms of action of infliximab. Alimentary Pharmacology & Therapeutics 13, pages 3-8.
Crossref
Crossref
Mamoru Watanabe, Yasuo Hosoda, Susumu Okamoto, Motomi Yamazaki, Nagamu Inoue, Yoshitaka Ueno, Yasushi Iwao, Hiromasa Ishii, Noriaki Watanabe, Yoshiki Hamada, Takaya Yamada, Tatsuo Suzuki & Toshifumi Hibi. (1998) CD45RChighCD4+Intestinal Mucosal Lymphocytes Infiltrating in the Inflamed Colonic Mucosa of a Novel Rat Colitis Model Induced by TNB Immunization. Clinical Immunology and Immunopathology 88:1, pages 46-55.
Crossref
Crossref
Hiroyuki Ogawa, Hiroaki Ito, Akira Takeda, Sumie Kanazawa, Mitsunari Yamamoto, Hideji Nakamura, Yoshihiro Kimura, Kazuyuki Yoshizaki & Tadamitsu Kishimoto. (1997) Universal Skew of T Cell Receptor (TCR) Vβ Usage for Crohn's Disease (CrD). Biochemical and Biophysical Research Communications 240:3, pages 545-551.
Crossref
Crossref
Stephan R. Targan, Stephen B. Hanauer, Sander J.H. van Deventer, Lloyd Mayer, Daniel H. Present, Tanja Braakman, Kimberly L. DeWoody, Thomas F. Schaible & Paul J. Rutgeerts. (1997) A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease. New England Journal of Medicine 337:15, pages 1029-1036.
Crossref
Crossref
WA Stack, SD Mann, AJ Roy, P Heath, M Sopwith, J Freeman, G Holmes, R Long, A Forbes, MA Kamm & CJ Hawkey. (1997) Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease. The Lancet 349:9051, pages 521-524.
Crossref
Crossref
HIROSHI SERIZAWA, SOICHIRO MIURA, HIROYUKI IMAEDA, SHIN TANAKA, HIROYUKI KIMURA, YOSHIKAZU TSUZUKI, HAN JING‐YANG, KYOKO TODA, YOSHIKI HAMADA, MASAHARU TSUCHIYA & HIROMASA ISHII. (2008) Reversal of altered intestinal mucosal immunity in rats fed elemental diet by supplementation of oleic acid. Journal of Gastroenterology and Hepatology 11:9, pages 811-818.
Crossref
Crossref
Hendrik M. van Dullemen, Sander J.H. van Deventer, Daan W. Hommes, Hannie A. Bijl, Jaap Jansen, Guido N.J. Tytgat & James Woody. (1995) Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:1, pages 129-135.
Crossref
Crossref